8037 Stock Overview
China Biotech Services Holdings Limited, eine Investment-Holdinggesellschaft, bietet medizinische Labortests und Gesundheitskontrollen in der Volksrepublik China und Hongkong an.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
China Biotech Services Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.38 |
52 Week High | HK$1.08 |
52 Week Low | HK$0.29 |
Beta | -0.57 |
1 Month Change | -6.25% |
3 Month Change | -41.41% |
1 Year Change | -62.50% |
3 Year Change | -70.47% |
5 Year Change | -75.33% |
Change since IPO | -96.88% |
Recent News & Updates
Recent updates
China Biotech Services Holdings Limited's (HKG:8037) Popularity With Investors Under Threat As Stock Sinks 31%
Mar 07Earnings Not Telling The Story For China Biotech Services Holdings Limited (HKG:8037) After Shares Rise 46%
Jan 18We Think China Biotech Services Holdings (HKG:8037) Might Have The DNA Of A Multi-Bagger
Jan 06Does China Biotech Services Holdings (HKG:8037) Have A Healthy Balance Sheet?
Dec 09These 4 Measures Indicate That China Biotech Services Holdings (HKG:8037) Is Using Debt Safely
Aug 24A Look At The Fair Value Of China Biotech Services Holdings Limited (HKG:8037)
Nov 05Is China Biotech Services Holdings (HKG:8037) A Risky Investment?
Oct 13What China Biotech Services Holdings Limited's (HKG:8037) 35% Share Price Gain Is Not Telling You
Jun 28China Biotech Services Holdings (HKG:8037) Could Become A Multi-Bagger
Mar 16China Biotech Services Holdings (HKG:8037) Knows How To Allocate Capital Effectively
Dec 01Under The Bonnet, China Biotech Services Holdings' (HKG:8037) Returns Look Impressive
Jul 26China Biotech Services Holdings' (HKG:8037) Robust Earnings Are Supported By Other Strong Factors
Apr 05Investors Shouldn't Overlook China Biotech Services Holdings' (HKG:8037) Impressive Returns On Capital
Mar 23Did You Miss China Biotech Services Holdings' (HKG:8037) Whopping 825% Share Price Gain?
Feb 23Chun-Shun Ko Just Bought 27% More Shares In China Biotech Services Holdings Limited (HKG:8037)
Jan 28What Is The Ownership Structure Like For China Biotech Services Holdings Limited (HKG:8037)?
Jan 11The Trend Of High Returns At China Biotech Services Holdings (HKG:8037) Has Us Very Interested
Dec 08Shareholder Returns
8037 | HK Healthcare | HK Market | |
---|---|---|---|
7D | 7.1% | -2.7% | 0.9% |
1Y | -62.5% | -33.0% | -13.2% |
Rendite im Vergleich zur Industrie: 8037 unter dem Niveau der Branche Hong Kong Healthcare , die im vergangenen Jahr eine Rendite von -19.5% erzielte.
Rendite vs. Markt: 8037 hinter dem Markt Hong Kong zurück, der im vergangenen Jahr eine Rendite von -13.7 erzielte.
Price Volatility
8037 volatility | |
---|---|
8037 Average Weekly Movement | 23.6% |
Healthcare Industry Average Movement | 7.1% |
Market Average Movement | 7.4% |
10% most volatile stocks in HK Market | 14.5% |
10% least volatile stocks in HK Market | 3.7% |
Stabiler Aktienkurs: 8037Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.
Volatilität im Zeitverlauf: 8037Die wöchentliche Volatilität der Aktie ist im vergangenen Jahr von 13% auf 20% gestiegen.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 162 | n/a | https://www.cbshhk.com |
China Biotech Services Holdings Limited, eine Investment-Holding, bietet medizinische Labortests und Gesundheitskontrollen in der Volksrepublik China und Hongkong an. Das Unternehmen ist in sechs Segmenten tätig: Medizinische und gesundheitsbezogene Dienstleistungen, Immuntherapie, pharmazeutische Produkte, Wertpapiere, Versicherungsmaklergeschäft, BNCT und andere Segmente. Das Unternehmen bietet außerdem medizinische Labortests und Gesundheitsprüfungen, Tumorimmuntherapie und Gesundheitsmanagement, Verkauf und Vertrieb von Gesundheitsprodukten und pharmazeutischen Produkten, Wertpapierhandel, Versicherungsmaklerdienste, Borneutroneneinfangtherapie, Geldverleih und Logistikdienstleistungen an.
China Biotech Services Holdings Limited Fundamentals Summary
8037 fundamental statistics | |
---|---|
Market cap | HK$361.21m |
Earnings (TTM) | -HK$95.45m |
Revenue (TTM) | HK$211.99m |
1.7x
P/S Ratio-3.8x
P/E RatioIs 8037 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8037 income statement (TTM) | |
---|---|
Revenue | HK$211.99m |
Cost of Revenue | HK$177.66m |
Gross Profit | HK$34.32m |
Other Expenses | HK$129.77m |
Earnings | -HK$95.45m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.099 |
Gross Margin | 16.19% |
Net Profit Margin | -45.03% |
Debt/Equity Ratio | 17.3% |
How did 8037 perform over the long term?
See historical performance and comparison